These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 9343406

  • 1. Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.
    Martínez-Martínez S, Gómez del Arco P, Armesilla AL, Aramburu J, Luo C, Rao A, Redondo JM.
    Mol Cell Biol; 1997 Nov; 17(11):6437-47. PubMed ID: 9343406
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
    Sancho R, Macho A, de La Vega L, Calzado MA, Fiebich BL, Appendino G, Muñoz E.
    J Immunol; 2004 Feb 15; 172(4):2341-51. PubMed ID: 14764703
    [Abstract] [Full Text] [Related]

  • 3. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.
    Aoki Y, Kao PN.
    Antimicrob Agents Chemother; 1999 Nov 15; 43(11):2678-84. PubMed ID: 10543746
    [Abstract] [Full Text] [Related]

  • 4. Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites.
    Saccani S, Saccani A, Varesio L, Ghosh P, Young HA, Sica A.
    Eur J Immunol; 1999 Apr 15; 29(4):1194-201. PubMed ID: 10229086
    [Abstract] [Full Text] [Related]

  • 5. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.
    Aramburu J, Azzoni L, Rao A, Perussia B.
    J Exp Med; 1995 Sep 01; 182(3):801-10. PubMed ID: 7650486
    [Abstract] [Full Text] [Related]

  • 6. Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds.
    Trevillyan JM, Chiou XG, Chen YW, Ballaron SJ, Sheets MP, Smith ML, Wiedeman PE, Warrior U, Wilkins J, Gubbins EJ, Gagne GD, Fagerland J, Carter GW, Luly JR, Mollison KW, Djuric SW.
    J Biol Chem; 2001 Dec 21; 276(51):48118-26. PubMed ID: 11592964
    [Abstract] [Full Text] [Related]

  • 7. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
    Márquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Muñoz E.
    J Pharmacol Exp Ther; 2004 Mar 21; 308(3):993-1001. PubMed ID: 14617683
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
    Paliogianni F, Boumpas DT.
    Cell Immunol; 1996 Jul 10; 171(1):95-101. PubMed ID: 8660843
    [Abstract] [Full Text] [Related]

  • 9. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C, Patriotis C, Tsichlis PN.
    Oncogene; 1998 Nov 19; 17(20):2609-18. PubMed ID: 9840924
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.
    Gringhuis SI, de Leij LF, Verschuren EW, Borger P, Vellenga E.
    Blood; 1997 Oct 01; 90(7):2690-700. PubMed ID: 9326236
    [Abstract] [Full Text] [Related]

  • 11. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1.
    Fortin JF, Barbeau B, Robichaud GA, Paré ME, Lemieux AM, Tremblay MJ.
    Blood; 2001 Apr 15; 97(8):2390-400. PubMed ID: 11290602
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.
    Irvin BJ, Williams BL, Nilson AE, Maynor HO, Abraham RT.
    Mol Cell Biol; 2000 Dec 15; 20(24):9149-61. PubMed ID: 11094067
    [Abstract] [Full Text] [Related]

  • 14. JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes.
    Gómez del Arco P, Martínez-Martínez S, Calvo V, Armesilla AL, Redondo JM.
    J Biol Chem; 1996 Oct 18; 271(42):26335-40. PubMed ID: 8824287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.